High analytical concordance between a novel companion diagnostic assay and an IUO assay for BRAF V600E/V600K detection in melanoma

被引：0
|
作者：
O'Donnell, L. [1 ]
Sweet, W. [1 ]
Lu, X. [1 ]
Meynier, F. [2 ]
Derome, A. [3 ]
Ganee, L. [4 ]
Poyet-Gelas, F. [3 ]
Martin, A. [5 ]
Casey, M. [6 ]
Kertesz, N. [7 ]
机构：
[1] BioMerieux Inc, Clin Affairs, Durham, NC USA
[2] BioMerieux Inc, BioMath, Grenoble, France
[3] BioMerieux Inc, V&V, Grenoble, France
[4] BioMerieux Inc, Prod Design & Dev, Grenoble, France
[5] GSK, Oncol, Collegeville, PA USA
[6] GSK, Stat, Collegeville, PA USA
[7] Response Genet Inc, Pharmaceut Liaison Manager, Los Angeles, CA USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MC13-0053
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [41] Differential Detection of BRAFV600E and V600K Using a Simple and Sensitive Droplet Digital PCR Assay
    Landry, L.
    Bellizzi, L.
    Bruce, J.
    Rojas-Rudilla, V.
    Diegue, S.
    Duchesne, A.
    Kuang, Y.
    Paweletz, C. P.
    Lindeman, N.
    Sholl, L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 1012 - 1013
  • [42] An Optimized CRISPR/Cas12a Assay to Facilitate the BRAF V600E Mutation Detection
    Etemadzadeh, Azadeh
    Salehipour, Pouya
    Motlagh, Fatemeh Movahedi
    Khalifeh, Masoomeh
    Asadbeigi, Adnan
    Tabrizi, Mina
    Shirkouhi, Reza
    Modarressi, Mohammad Hossein
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2024, 38 (21)
  • [43] Development of a mismatch repair immunohistochemistry clinical trial assay and novel BRAF V600E antibody
    Finkelstein, H.
    Tennant, V.
    Mayhew, C.
    Soleimani, S.
    Tabuena-Frolli, S.
    Lee, J.
    Haase, T.
    Aidt, F.
    Oroudjev, E.
    VIRCHOWS ARCHIV, 2019, 475 : S199 - S199
  • [44] Enzymatic Enrichment of BRAF V600E Mutations: A Method to Improve Assay Sensitivity
    Ma, L.
    Maj, A.
    Baltadjieva, B.
    Mazur, L.
    Mihalov, M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 748 - 748
  • [45] Two cases of metastatic conjunctival melanoma with BRAF V600K mutations
    Sauer, V. P.
    Amschler, K.
    Cihan, Y.
    Woelling, A.
    Schoen, M. P.
    Thoms, K. M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 55 - 55
  • [46] Encorafenib and binimetinib for the treatment of BRAF V600E/K-mutated melanoma
    Rose, A. A. N.
    DRUGS OF TODAY, 2019, 55 (04) : 247 - 264
  • [47] NGS Profiling of BRAF V600E and V600K Positive Metastatic Melanomas to Identify Additional Prognostic Markers and Potential Therapeutic Targets
    Mina, K.
    Leslie, C.
    Tabone, T.
    Grieu-Iacopetta, F.
    Millward, M.
    Erber, W.
    Amanuel, B.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 759 - 760
  • [48] Immunohistochemistry Is Highly Sensitive and Specific for the Detection of V600E BRAF Mutation in Melanoma
    Long, Georgina V.
    Wilmott, James S.
    Capper, David
    Preusser, Matthias
    Zhang, Yuxiao E.
    Thompson, John F.
    Kefford, Richard F.
    von Deimling, Andreas
    Scolyer, Richard A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (01) : 61 - 65
  • [49] Value of immunohistochemistry for detection of BRAF V600E mutation
    Kern, I.
    Vlacic, G.
    VIRCHOWS ARCHIV, 2020, 477 : S361 - S361
  • [50] Determination of the mutation BRAF V600E in melanoma patients Uruguayans
    Eugenia Mazzei, Maria
    Hochmann, Jimena
    Manrique, Gonzalo
    Luisa Marino, Ana
    Delgado, Lucia
    Martinez Asuaga, Miguel
    REVISTA MEDICA DEL URUGUAY, 2013, 29 (02): : 97 - 102
12345